Orbital Neoplasms in Adults: Clinical, Radiologic, and Pathologic Review

Published Online:https://doi.org/10.1148/rg.336135502

Cross-sectional CT and MR imaging studies supplement fundoscopic and clinical ophthalmologic examination in patients with orbital neoplasms, providing diagnostic information and facilitating treatment planning by allowing precise identification of disease extent.

Orbital neoplasms in adults may be categorized on the basis of location and histologic type. Imaging features of these lesions often reflect their tissue composition. Cavernous malformations (also known as cavernous hemangiomas), although not true neoplasms, are the most common benign adult orbital tumor. They typically appear as a well-circumscribed, ovoid intraconal mass on cross-sectional images. Lymphoma, which may be primary or secondary to systemic disease, is the most prevalent orbital neoplasm in older adults (≥60 years of age). Choroidal melanoma is the most common primary adult ocular malignancy. Melanin has intrinsic T1 and T2 shortening effects, classically manifesting with hyperintense signal on T1-weighted magnetic resonance (MR) images and with hypointense signal on T2-weighted images. However, amelanotic or mildly pigmented lesions of melanoma do not demonstrate these characteristic MR imaging features. Breast cancer is the most common malignancy to metastasize to the orbit, followed by prostate cancer, melanoma, and lung cancer. In women with bilateral enophthalmos, metastatic scirrhous breast cancer should be considered in the differential diagnosis. Neoplasms that arise from the optic nerve or its sheath include glioma and meningioma. At imaging, gliomas often cause fusiform expansion of the optic nerve, in which the nerve itself cannot be delineated from the lesion. In contrast, meningiomas classically have a “tram-track” configuration, whereby the contrast-enhancing tumor is seen alongside the optic nerve. Neoplasms that derive from peripheral nerves include schwannoma and neurofibroma, the latter of which is associated with neurofibromatosis type 1. MR imaging is particularly valuable for evaluation of orbital neoplasms, as it provides critical anatomic information about ocular structures involved, perineural spread, and intracranial extension.

References

  • 1 Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 2004;111(5):997–1008.
  • 2 Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 2012;47(2):106–117.
  • 3 Smoker WR, Gentry LR, Yee NK, Reede DL, Nerad JA. Vascular lesions of the orbit: more than meets the eye. RadioGraphics 2008;28(1):185–204.
  • 4 Harris GJ, Jakobiec FA. Cavernous hemangioma of the orbit. J Neurosurg 1979;51(2):219–228.
  • 5 Ansari SA, Mafee MF. Orbital cavernous hemangioma: role of imaging. Neuroimaging Clin N Am 2005;15(1):137–158.
  • 6 Wang Y, Xiao LH. Orbital schwannomas: findings from magnetic resonance imaging in 62 cases. Eye (Lond) 2008;22(8):1034–1039.
  • 7 Yousem DM, Zimmerman RD, Grossman RI. Neuroradiology: the requisites. Philadelphia, Pa: Mosby, 2010.
  • 8 Croxatto JO, Font RL. Hemangiopericytoma of the orbit: a clinicopathologic study of 30 cases. Hum Pathol 1982;13(3):210–218.
  • 9 Ruchman MC, Flanagan J. Cavernous hemangiomas of the orbit. Ophthalmology 1983;90(11): 1328–1336.
  • 10 Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology 2006;48(1):63–74.
  • 11 Park MS, Araujo DM. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Curr Opin Oncol 2009; 21(4):327–331.
  • 12 Goldsmith JD, van de Rijn M, Syed N. Orbital hemangiopericytoma and solitary fibrous tumor: a morphologic continuum. Int J Surg Pathol 2001; 9(4):295–302.
  • 13 Demirci H, Shields CL, Shields JA, Honavar SG, Mercado GJ, Tovilla JC. Orbital tumors in the older adult population. Ophthalmology 2002;109(2):243–248.
  • 14 Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology 2008;115(9):1626–1631, 1631.e1–e3.
  • 15 Rosa RH, Buggage R, Harocopos GJ, et al.. Ophthalmic pathology and intraocular tumors. San Francisco, Calif: American Academy of Ophthalmology, 2011.
  • 16 Valvassori GE, Sabnis SS, Mafee RF, Brown MS, Putterman A. Imaging of orbital lymphoproliferative disorders. Radiol Clin North Am 1999;37(1): 135–150.
  • 17 Cytryn AS, Putterman AM, Schneck GL, Beckman E, Valvassori GE. Predictability of magnetic resonance imaging in differentiation of orbital lymphoma from orbital inflammatory syndrome. Ophthal Plast Reconstr Surg 1997;13(2):129–134.
  • 18 Sepahdari AR, Aakalu VK, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF. Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. Radiology 2010;256(2):554–564.
  • 19 Shields CL, Shields JA. Lacrimal gland tumors. Int Ophthalmol Clin 1993;33(3):181–188.
  • 20 Jung WS, Ahn KJ, Park MR, et al.. The radiological spectrum of orbital pathologies that involve the lacrimal gland and the lacrimal fossa. Korean J Radiol 2007;8(4):336–342.
  • 21 Mafee MF, Edward DP, Koeller KK, Dorodi S. Lacrimal gland tumors and simulating lesions: clinicopathologic and MR imaging features. Radiol Clin North Am 1999;37(1):219–239.
  • 22 Bernardini FP, Devoto MH, Croxatto JO. Epithelial tumors of the lacrimal gland: an update. Curr Opin Ophthalmol 2008;19(5):409–413.
  • 23 Rasmussen P, Ralfkiaer E, Prause JU, Sjö LD, Siersma VD, Heegaard S. Malignant lymphoma of the lacrimal gland: a nation-based study. Arch Ophthalmol 2011;129(10):1275–1280.
  • 24 Lloyd GA. Lacrimal gland tumours: the role of CT and conventional radiology. Br J Radiol 1981;54(648):1034–1038.
  • 25 Politi LS, Forghani R, Godi C, et al.. Ocular adnexal lymphoma: diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring. Radiology 2010;256(2):565–574.
  • 26 Boukes RJ, de Vries-Knoppert WA. Lacrimal gland enlargement as one of the ocular manifestations of Wegener’s granulomatosis. Doc Ophthalmol 1985; 59(1):21–26.
  • 27 Raskin EM, McCormick SA, Maher EA, Della Rocca RC. Granulomatous idiopathic orbital inflammation. Ophthal Plast Reconstr Surg 1995;11(2):131–135.
  • 28 Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol 2011;31(3):269–278.
  • 29 Kornreich L, Blaser S, Schwarz M, et al.. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 2001;22(10):1963–1969.
  • 30 Mafee MF, Goodwin J, Dorodi S. Optic nerve sheath meningiomas: role of MR imaging. Radiol Clin North Am 1999;37(1):37–58.
  • 31 Kanamalla US. The optic nerve tram-track sign. Radiology 2003;227(3):718–719.
  • 32 Miller NR. Primary tumours of the optic nerve and its sheath. Eye (Lond) 2004;18(11):1026–1037.
  • 33 Garg R, Dhawan A, Gupta N, D’souza P. A rare case of benign isolated schwannoma in the inferior orbit. Indian J Ophthalmol 2008;56(6):514–515.
  • 34 Xian J, Zhang Z, Wang Z, et al.. Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit. Eur Radiol 2010;20(9):2221–2228.
  • 35 Messmer EP, Camara J, Boniuk M, Font RL. Amputation neuroma of the orbit: report of two cases and review of the literature. Ophthalmology 1984; 91(11):1420–1423.
  • 36 De Potter P, Shields CL, Shields JA, Rao VM, Eagle RC, Trachtenberg WM. The CT and MRI features of an unusual case of isolated orbital neurofibroma. Ophthal Plast Reconstr Surg 1992; 8(3):221–227.
  • 37 Graeb DA, Rootman J, Robertson WD, Lapointe JS, Nugent RA, Hay EJ. Orbital lymphangiomas: clinical, radiologic, and pathologic characteristics. Radiology 1990;175(2):417–421.
  • 38 Carroll GS, Haik BG, Fleming JC, Weiss RA, Mafee MF. Peripheral nerve tumors of the orbit. Radiol Clin North Am 1999;37(1):195–202.
  • 39 Theos A, Korf BR; American College of Physicians; American Physiological Society. Pathophysiology of neurofibromatosis type 1. Ann Intern Med 2006;144(11):842–849.
  • 40 Aydin MD, Yildirim U, Gundogdu C, Dursun O, Uysal HH, Ozdikici M. Malignant peripheral nerve sheath tumor of the orbit: case report and literature review. Skull Base 2004;14(2):109–113; discussion 113–114.
  • 41 Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma. Cancer Treat Rev 2012;38(5):549–553.
  • 42 Grin JM, Grant-Kels JM, Grin CM, Berke A, Kels BD. Ocular melanomas and melanocytic lesions of the eye. J Am Acad Dermatol 1998;38(5 Pt 1): 716–730.
  • 43 Shields CL, Shields JA, Materin M, Gershenbaum E, Singh AD, Smith A. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology 2001;108(1):172–178.
  • 44 The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9. Am J Ophthalmol 1998;125(6):767–778.
  • 45 Mafee MF. Uveal melanoma, choroidal hemangioma, and simulating lesions: role of MR imaging. Radiol Clin North Am 1998;36(6):1083–1099.
  • 46 Lemke AJ, Hosten N, Bornfeld N, et al.. Uveal melanoma: correlation of histopathologic and radiologic findings by using thin-section MR imaging with a surface coil. Radiology 1999;210(3):775–783.
  • 47 De Potter P, Shields JA, Shields CL, Yannuzzi LA, Fisher YE, Rao VM. Unusual MRI findings in metastatic carcinoma to the choroid and optic nerve: a case report. Int Ophthalmol 1992;16(1):39–44.
  • 48 Freedman MI, Folk JC. Metastatic tumors to the eye and orbit: patient survival and clinical characteristics. Arch Ophthalmol 1987;105(9):1215–1219.
  • 49 Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle RC. Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthal Plast Reconstr Surg 2001;17(5):346–354.
  • 50 Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104(8):1265–1276.
  • 51 Ahmad SM, Esmaeli B. Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol 2007; 18(5):405–413.
  • 52 Goldberg RA, Rootman J, Cline RA. Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol 1990;35(1):1–24.
  • 53 Meltzer DE, Chang AH, Shatzkes DR. Case 152: orbital metastatic disease from breast carcinoma. Radiology 2009;253(3):893–896.
  • 54 Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestations of sarcoidosis in various organs. RadioGraphics 2004;24(1):87–104.

Article History

Received: Feb 1 2013
Revision requested: Mar 4 2013
Revision received: Mar 23 2013
Accepted: Apr 3 2013
Published online: Oct 1 2013
Published in print: Oct 2013